Environmental

ENOV’s R&D intensity at 5.4% of revenue suggests moderate product-development investment, but peers in medtech often spend more to support lower-impact innovation and lifecycle redesign.

The company’s capital structure data do not indicate a clear environmental advantage, because leverage metrics are financial rather than ESG drivers and provide no evidence of superior resource efficiency versus peers.

No filing-based evidence provided here shows stronger emissions, energy, or waste management performance, so ENOV cannot be assessed as environmentally leading relative to medtech peers.

Absent disclosed environmental targets or operational metrics, ENOV appears broadly in line with mid-pack peers rather than structurally advantaged on material environmental factors.

Social

ENOV’s low stock-based compensation at 1.2% of revenue suggests restrained dilution, but it does not by itself demonstrate stronger workforce alignment than peers.

The provided metrics do not show employee safety, retention, or product-access outcomes, limiting evidence of a social advantage versus larger medtech peers with more disclosed programs.

R&D spending supports ongoing product improvement, yet without clinical, quality, or access disclosures, ENOV’s social positioning remains difficult to distinguish from peers.

On the available evidence, ENOV appears neither socially weak nor clearly differentiated, leaving it close to the peer median on material social factors.

Governance

ENOV’s debt-to-equity ratio of 0.93 indicates moderate balance-sheet leverage, which is generally less aggressive than many peers and supports governance discipline.

Negative net debt to EBITDA suggests net cash positioning, reducing refinancing pressure and lowering the governance risk associated with creditor dependence versus leveraged peers.

Stock-based compensation at 1.2% of revenue is relatively contained, implying more disciplined executive dilution than peers with heavier equity-based pay structures.

No controversy or control-failure evidence is provided, so ENOV’s governance profile appears stronger than average primarily due to conservative capital and compensation discipline.

Overall Score

ENOV’s ESG profile is broadly middle-of-the-pack, with governance modestly stronger than peers while environmental and social disclosure remains insufficient to show clear leadership.

Score Driver: Governance Discipline From Moderate Leverage And Low Dilution Is The Main Relative Strength.